Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Restructuring Costs (2018 - 2019)

Rockwell Medical (RMTI) has disclosed Restructuring Costs for 2 consecutive years, with $430000.0 as the latest value for Q2 2019.

  • For the quarter ending Q2 2019, Restructuring Costs fell 58.25% year-over-year to $430000.0, compared with a TTM value of $430000.0 through Sep 2020, down 70.55%, and an annual FY2019 reading of $430000.0, down 58.25% over the prior year.
  • Restructuring Costs was $430000.0 for Q2 2019 at Rockwell Medical, down from $1.0 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $1.0 million in Q2 2018 and bottomed at $430000.0 in Q2 2019.